These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 10671332

  • 21. Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study.
    Kelsey SM, Goldman JM, McCann S, Newland AC, Scarffe JH, Oppenheim BA, Mufti GJ.
    Bone Marrow Transplant; 1999 Jan; 23(2):163-8. PubMed ID: 10197802
    [Abstract] [Full Text] [Related]

  • 22. A controlled trial of itraconazole as primary prophylaxis for systemic fungal infections in patients with advanced human immunodeficiency virus infection in Thailand.
    Chariyalertsak S, Supparatpinyo K, Sirisanthana T, Nelson KE.
    Clin Infect Dis; 2002 Jan 15; 34(2):277-84. PubMed ID: 11740718
    [Abstract] [Full Text] [Related]

  • 23. Invasive fungal infections in pediatric patients with hematologic malignancies receiving oral amphotericin B solution and early intravenous administration of fluconazole.
    Watanabe N, Matsumoto K, Kojima S, Kato K.
    J Pediatr Hematol Oncol; 2011 May 15; 33(4):270-5. PubMed ID: 21464763
    [Abstract] [Full Text] [Related]

  • 24. Itraconazole prophylaxis for invasive gingival aspergillosis in neutropenic patients with acute leukemia.
    Myoken Y, Sugata T, Kyo T, Fujihara M, Mikami Y.
    J Periodontol; 2002 Jan 15; 73(1):33-8. PubMed ID: 11846198
    [Abstract] [Full Text] [Related]

  • 25. Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial).
    Cornely OA, Maertens J, Bresnik M, Ebrahimi R, Ullmann AJ, Bouza E, Heussel CP, Lortholary O, Rieger C, Boehme A, Aoun M, Horst HA, Thiebaut A, Ruhnke M, Reichert D, Vianelli N, Krause SW, Olavarria E, Herbrecht R, AmBiLoad Trial Study Group.
    Clin Infect Dis; 2007 May 15; 44(10):1289-97. PubMed ID: 17443465
    [Abstract] [Full Text] [Related]

  • 26. Randomized placebo-controlled trial of fluconazole prophylaxis for neutropenic cancer patients: benefit based on purpose and intensity of cytotoxic therapy. The Canadian Fluconazole Prophylaxis Study Group.
    Rotstein C, Bow EJ, Laverdiere M, Ioannou S, Carr D, Moghaddam N.
    Clin Infect Dis; 1999 Feb 15; 28(2):331-40. PubMed ID: 10064252
    [Abstract] [Full Text] [Related]

  • 27. Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. National Institute of Allergy and Infectious Diseases Mycoses Study Group.
    McKinsey DS, Wheat LJ, Cloud GA, Pierce M, Black JR, Bamberger DM, Goldman M, Thomas CJ, Gutsch HM, Moskovitz B, Dismukes WE, Kauffman CA.
    Clin Infect Dis; 1999 May 15; 28(5):1049-56. PubMed ID: 10452633
    [Abstract] [Full Text] [Related]

  • 28. [Itraconazole 800 mg for the prophylaxis of fungal infections in patients with acute leukemia and severe neutropenia].
    Andrade M A, Puga L B, Guerra C C, Molina E J, Capurro C M.
    Rev Med Chil; 2011 Sep 15; 139(9):1128-34. PubMed ID: 22215390
    [Abstract] [Full Text] [Related]

  • 29. Efficacy and safety of itraconazole as empirical antifungal therapy in febrile neutropenic patients with hematologic malignancies: an open-lable, multicenter, observational trial in a Chinese cohort.
    Cheng S, Zhou JF, Zou P, Huang XJ, Jin J, Shen ZX.
    Chin Med J (Engl); 2011 Nov 15; 124(22):3670-5. PubMed ID: 22340222
    [Abstract] [Full Text] [Related]

  • 30. Intravenous itraconazole for prophylaxis of systemic fungal infections in patients with acute myelogenous leukemia and high-risk myelodysplastic syndrome undergoing induction chemotherapy.
    Mattiuzzi GN, Kantarjian H, O'Brien S, Kontoyiannis DP, Giles F, Zhou X, Lim J, Bekele BN, Faderl S, Cortes J, Pierce S, Leitz GJ, Raad I, Estey E.
    Cancer; 2004 Feb 01; 100(3):568-73. PubMed ID: 14745874
    [Abstract] [Full Text] [Related]

  • 31. A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML).
    Vehreschild JJ, Böhme A, Buchheidt D, Arenz D, Harnischmacher U, Heussel CP, Ullmann AJ, Mousset S, Hummel M, Frommolt P, Wassmer G, Drzisga I, Cornely OA.
    J Infect; 2007 Nov 01; 55(5):445-9. PubMed ID: 17822770
    [Abstract] [Full Text] [Related]

  • 32. Safety and efficacy of itraconazole in prevention of fungal infections in neutropenic patients.
    Thunnissen PL, Sizoo W, Hendriks WD.
    Neth J Med; 1991 Aug 01; 39(1-2):84-91. PubMed ID: 1660108
    [Abstract] [Full Text] [Related]

  • 33. Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome.
    Mattiuzzi GN, Estey E, Raad I, Giles F, Cortes J, Shen Y, Kontoyiannis D, Koller C, Munsell M, Beran M, Kantarjian H.
    Cancer; 2003 Jan 15; 97(2):450-6. PubMed ID: 12518369
    [Abstract] [Full Text] [Related]

  • 34. Prophylactic action of oral fluconazole against fungal infection in neutropenic patients. A meta-analysis of 16 randomized, controlled trials.
    Kanda Y, Yamamoto R, Chizuka A, Hamaki T, Suguro M, Arai C, Matsuyama T, Takezako N, Miwa A, Kern W, Kami M, Akiyama H, Hirai H, Togawa A.
    Cancer; 2000 Oct 01; 89(7):1611-25. PubMed ID: 11013378
    [Abstract] [Full Text] [Related]

  • 35. Successful bone marrow transplantation in patients with previous invasive fungal infections: report of four cases.
    Martino R, Nomdedéu J, Altés A, Sureda A, Brunet S, Martínez C, Domingo-Albós A.
    Bone Marrow Transplant; 1994 Mar 01; 13(3):265-9. PubMed ID: 8199569
    [Abstract] [Full Text] [Related]

  • 36. Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination.
    Trenschel R, Peceny R, Runde V, Elmaagacli A, Dermoumi H, Heintschel von Heinegg E, Müller KD, Schaefer UW, Beelen DW.
    Bone Marrow Transplant; 2000 Nov 01; 26(9):993-7. PubMed ID: 11100279
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials.
    Bow EJ, Laverdière M, Lussier N, Rotstein C, Cheang MS, Ioannou S.
    Cancer; 2002 Jun 15; 94(12):3230-46. PubMed ID: 12115356
    [Abstract] [Full Text] [Related]

  • 39. Amphotericin B colloidal dispersion (Amphocil) vs fluconazole for the prevention of fungal infections in neutropenic patients: data of a prematurely stopped clinical trial.
    Timmers GJ, Zweegman S, Simoons-Smit AM, van Loenen AC, Touw D, Huijgens PC.
    Bone Marrow Transplant; 2000 Apr 15; 25(8):879-84. PubMed ID: 10808210
    [Abstract] [Full Text] [Related]

  • 40. Safety of a weekly high dose of liposomal amphotericin B for prophylaxis of invasive fungal infection in immunocompromised patients: PROPHYSOME Study.
    Cordonnier C, Mohty M, Faucher C, Pautas C, Robin M, Vey N, Monchecourt F, Mahi L, Ribaud P.
    Int J Antimicrob Agents; 2008 Feb 15; 31(2):135-41. PubMed ID: 18162375
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.